Corbion N.V. — Capital/Financing Update 2014

Jun 13, 2014

Corbion nv Nienoord 13 • 1112 XE Diemen PO Box 349 • 1000 AH Amsterdam The Netherlands

T +31 (0)20 590 6911 Press@corbion.com www.corbion.com www.meetcorbion.com

PRESS RELEASE

DATE 13 June 2014

Corbion renewed Revolving Credit Facility

Corbion announces that the company successfully closed a 5 years syndicated loan facility of EUR 300 million.

The new Revolving Credit Facility (RCF) replaces the company's existing RCF. The syndicate for this RCF contains seven banks.

Eddy van Rhede van der Kloot, CFO: "This RCF will give us the necessary flexibility in our funding needs to execute our investment plans in the coming years. Participation to provide this facility to Corbion was oversubscribed".

For more information, please contact:

Press: Saskia Nuijten, Director Corporate Communications T +31 (0)20 5906320, M +31 (0)6 21 812 453 Analysts and investors: Jeroen van Harten, Director Investor Relations

T +31 (0)20 5906293, M +31(0)6 21 577 086

Background information:

Corbion: biobased solutions, designed by science, powered by nature, and delivered through dedication.

Corbion is the global market leader in lactic acid, lactic acid derivatives and lactides, and a leading company in functional blends containing enzymes, emulsifiers, minerals and vitamins. The company delivers high performance biobased products made from renewable resources and applied in global markets such as bakery, meat, pharmaceuticals and medical devices, home and personal care, packaging, automotive, coatings and resins. Its products have a differentiating functionality in all kinds of consumer products worldwide. In 2013, Corbion generated annual sales of €743.6 million and had a workforce of 1,885 employees. Corbion is listed on NYSE Euronext Amsterdam. For more information: www.corbion.com